(Q40009915)

16 September 2017

title

The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease (English)

1 reference

16 September 2017

Z Aitken

0 references

G Dreyer

1 reference

16 September 2017

S Hull

series ordinal

1 reference

16 September 2017

A Chesser

series ordinal

1 reference

16 September 2017

M M Yaqoob

series ordinal

1 reference

16 September 2017

language of work or name

English

0 references

publication date

15 January 2009

1 reference

QJM: An International Journal of Medicine

16 September 2017

published in

1 reference

16 September 2017

volume

102

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

261-269

1 reference

Chronic kidney disease management in the United Kingdom: NEOERICA project results.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

The association between atherosclerotic risk factors and renal function in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy: race and ethnicity considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN177

21 January 2018

Identifiers

DOI

10.1093/QJMED/HCN177

1 reference

16 September 2017

1 reference